chrisvoncsefalvay/vaers-outcomes huggingface dataset:
General swelling in the armpit under the shoulder that received the injection. It's sore, and making my arm lightly achy and my hand tingle off and on. I assume it is due to the lymp nodes being super-activated under there. I have had Covid-19 twice (May 2020 and Jan 2021) and guess it may be related to a super-ready immune system. Also, it has re-activated some of the covid symptoms--chills, exhaustion, headache, and a dimming of my taste and smell, which had not even fully returned since the January 20021 bout of Covid. Now I can only discern sweet/sour/salty, with a momentary hint of what I'm eating during the first bite or sip, before it's gone again. Complex mixes of foods, like a taco, for instance, would taste like nothing at all. Zero. Single note flavors, such as orange juice, are weakly flavored at first, then gone after a taste or two, like the tastebuds are used up. Most of the ability to smell is weak again, as well. I do wonder if the losses are due to inflammation response and not the virus activity itself, in light of this?none
Rash (scaly spots appeared over the left upper extremity and back - this isn't an uncommon autoimmune response for this patient) Brain fog Word finding difficulties Suspected decreased seizure threshold - unclear if partial seizure was elicited  Intense fatigue Increased sleep  Treatment: monitored for 30 minutes status post vaccine injection without any notable concerns; routine observation and monitoring given seizure history  Time course: Rash lasted for 1 week; Brain fog/word finding difficulties last fully for 10 days, then started to dissipate; Fatigue and increased sleep lasted 1 week
As mom leaving office she noted redness and some hives on left leg, then went down to knee area at about 10:15 A 6-17-10. Notified ordering physician and applied cold compress and observed for 20 min.
A vaccine was give on 02/22/01 at approximately 2 PM. It was noticed that approximately 3 hrs later, the left arm (below shoulder to elbow) was warm, and a purplish color. She was taken to the doctor at 12 noon on 02/24/01. The doctor felt he couldn't confirm a prescription . Went back to doctor on Sunday and he felt it was a reaction.
Pfizer-BioNTech COVID-19 Vaccine EUA  There may be a connection between the Pfizer COVID-19 vaccine and a recent heart attack that I experienced.  See Continuation Page There may be a connection between the Pfizer COVID-19 vaccine and a recent heart attack that I experienced.  Some history: I have been experiencing pain in my upper back that frequently radiated to my chest for about four years. After visits to my primary care physician, a rheumatologist, an orthopedic surgeon, a cardiologist and a visit to the emergency room, the only consensus was that this was not cardiac related, but was probably caused by a pinched nerve in my spine. This pain occurred primarily while walking, but was light to moderate and disappeared as soon I as stopped.   In December 2020, I consulted a cardiologist for heart palpitations. He recommended that I receive a calcium score test. Since this showed moderate risk in two arteries, he referred me for an echocardiogram and a nuclear stress test, both of which were normal. Based on these results, he felt that my condition was stable and recommended against catherization.  I received my first Pfizer vaccine shot on 2/12/2021. The only initial side effect was a sore arm that lasted for a day. However, about two weeks after the first shot, I went for a two mile walk. Soon after I started, I experienced intense pain in my back that radiated to my chest and left arm. I returned home and the pain subsided quickly. Given my history, I attributed the pain to my supposed pinched nerve. I tried walking on a couple of successive days, with the same result.   I received my second vaccination on 3/5/2021. I began to experience intense pain in my back that radiated to my chest and left arm about 16 hours later. This pain occurred despite resting the entire time. At first it was intermittent, but became steady after a couple of hours. I then decided to go to an emergent care center, where I was told that I was experiencing a heart attack. I was transferred to the emergency room at Hospital, and later admitted to the hospital where I underwent a catherization in which a stent was inserted in one artery and the other artery was unclogged.   I may have contracted covid in July, 2020. At that time I experienced a mild sore throat, fatigue and body aches. A covid test (PCR) was negative. However, the sore throat persisted for several months. My primary care physician recommended against an antibody test.
15 minutes after I had the dose, I felt chills, arthritic pain in all my joints, and lethargic.  It got progressively worse and 2 days later, I felt like my blood sugar was high and it was 507 and this was taking Metformin. So I went to the hospital. They were able to get my BS under control. the next day it was high again and they had me come back. I went to the ER 2 days in a roll. For my arthritic pain the hospital prescribed muscle relaxer. My real concern was my blood sugar being so high, but they were able to get it under control. I still have joint pain.
8/2--8/4 78 yo female w/ hx of recent COVID, HTN, HLP, PVD, Carotid artery dz, GERD, H pylori, asthma,hypothyroidism who presented to BHS-RO ED secondary to CP.  Recent hospitalization for COVID and NSTEMI. 2D echo w/ EF 60%, no WMA, small pericardial effusion w/o compromise. Completed hep gtt x 48h. Recommended OP ischemic work up. Pt overall did well and was discharged home. Pt w/ intermittent L sided burning chest pain w/ radiation to her back and shoulder over the past 1.5 weeks. Chest pain did get worse therefore she came to BHS-RO ED for further evaluation. Upon arrival to ED, 159/95, HR 93, afebrile, no hypoxia. No leukocytosis, Hgb 12.4, plts 157k. Lytes/renal function WNL. Cr 0.95. Trops WNL, BNP 43. COVID remains positive. CTA PE w/o thrombus , 3-vessel dz noted. Noted Extensive vascular calcifications and complete occlusion of the proximal left subclavian artery with a patent shunt through left carotid artery. Pt admitted for further care with cardio consult. Stress MPI done - no ischemia. Pt feeling well and agreeable for DC on 8/4. Pt notes she cannot tolerate statin. Pt was feeling well on day of discharge and medically stable for discharge. Pt was present during discharge planning and agreeable to plan.
A 31-year-old female patient, had received intramuscular dose 1 of ADACEL vaccine (lot number: U4612AA and site if administration was not reported) on 15 August 2013. The patient's last menstrual period date was 06 January 2013 and the expected date if delivery was reported as 13 October 2013. The patient's health during pregnancy, concomitant medications, medical history and risk factors were not reported. At the time of this report, the patient had not experienced any adverse event. List of documents held by sender: None.
Mild reactions including breathing heavy, throat felt swollen while trying to sleep, slight dizziness, some rashes(similar to big mosquito bites).  All reactions are mild.
Fever Chills, fatigue, slight cough, excessive sweating at night Narrative:
Little tired; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (Little tired) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Little tired). At the time of the report, FATIGUE (Little tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-122457 (Patient Link).
Had the shots, get this virus over and over/ Suspected vaccination failure; Get this horrible virus over and over; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had the shots, get this virus over and over/ Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Get this horrible virus over and over). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 14-Mar-2023 This case was reported by a patient via interactive digital media. The patient stated that he or she had the shots too and guessed that he or she was the only one who was going to get this horrible virus over and over. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up was not possible, as no contact details were available.
sever headache, body aches, tiredness, soar throat, low fever of about 100
Full body hives. The hives would pop up, after a few minutes they would go away and return in other locations. He had these on face, neck, arms, legs, trunk and feet. He also screamed continuously for 2.5 hours. I was instructed to give antihistamine which helped. The hives persisted for 1 week. Then went away.
The patient stated she was hospitalized due to severe fever, vomiting, and diarrhea.
Woke with rigors and temperature of 102.5, body aches and extreme fatigue.  Additional fever next evening.  Spent two days in bed.  As of today, 15FEB21, still have fatigue and some body aches and headaches.  Have been taking Acetaminophen.
After 1st vaccination, patient had symptoms of pain in shoulder and neck with some difficulty swallowing. I directed the patient to be cleared by primary care physician before second dose would be given.
Myalgia, Arthralgia, SkinRash, Diarrhea, Paresthesia of R hand fingers Narrative:
It was within 5 minutes, she started having hives that went down her arm and spread to other arm, face, trunk, legs, stomach. I went and got a nurse and she called a pediatric team - three nurses and one doctor - they took her vitals and gave her some Benadryl - 30 ML (children's). They had her sit and drink a bottle of water. We watched to see if the swelling and the hives would shrink and go away. It was probably about 20 minutes later where they went away, but she developed a headache and she was nauseated. We administered Benadryl (gave her regular 25 mg tablet every 6 hours)  for the next 24 hors in the dosage times. She was nauseated the first day and she had headache for two days. The hives went away by the time she went to bed the evening of the vaccine.
occipital neuralgia; Horrible head pain right side from base of scull to forehead and jaws and teeth and eye and ear; Horrible head pain right side from base of scull to forehead and jaws and teeth and eye and ear; Horrible head pain right side from base of scull to forehead and jaws; Horrible head pain right side from base of scull to forehead and jaws and teeth; Horrible head pain right side from base of scull to forehead and jaws and teeth and eye; Pain radiates down neck and trapezoid on right.; Pain radiates down neck and trapezoid on right.; This is a spontaneous report from a contactable consumer (patient). A 61-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EP7534) via an unspecified route of administration in left arm on an unspecified date in Mar2021 as single dose for COVID-19 immunization. Medical history of the patient included diabetes, pulmonary embolisms from trauma, kidney stones. Concomitant (other) medications in two weeks included metformin and glipizide taken for Diabetes and warfarin sodium [COUMADIN] taken for an unspecified indication. Patient did not receive any other vaccine in four weeks of COVID vaccine. Patient did not have COVID prior vaccination and was not tested for COVID post vaccination. Patient has allergy to mushrooms, iodine dye, aloe. On an unspecified date in Mar2021, patient experienced horrible head pain right side from base of skull to forehead and jaws and teeth and eye and ear, originally called occipital neuralgia. Pain was still there after 5 months. 10 on scale of 1 to 10. Pain radiates down neck and trapezoid on right. Patient never had headaches before this shot. Patient was taking oxycodone and gabapenten and Memantine. Adverse event resulted in visit to Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Reporter assessed events as serious causing Disability or permanent damage. Corrective treatment included Pain meds, acupuncture and cupping, TENS. Outcome of the events were not recovered.
VAERS  March 14, 2021  Dear Sir or Madame,   On Saturday, February 20, 2021 I received my first Moderna shot at the pharmacy. I will be getting my second shot on Saturday, March 20, 2021.  The reason for writing this letter is that I experienced left arm discomfort from February 20, 2021 to March 14., 2021. It even still hurts, but not as much. I applied hot compress, took Aleve 220 mg and St. Joseph 81 mg aspirin, applied Asper creme+Lidocaine and Icy Hot Lidocaine + menthol. None of this helped.  Attached is the form I filled out for VAERS. I would like this information be put in my records. I am giving a copy to my family doctor and a copy to the pharmacy.  I have spoken to the pharmacy where I get my prescriptions and other preventive shots, the pharmacy that administered the Moderna vaccine, and my family doctor. They all said there are reports about sore arms.  I hope my second shot will not be as painful.
R thigh red, swollen, hot to touch. Redness measured 11x19.5cm. Benadryl given in office Rx for Atarax and Orapred x 5 days.
no other AE; Caller is a pharmacist who reports a temperature excursion involving VARIVAX. He does not know whether any doses were administered following the temperature excursion.; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies were not reported.  On an unknown date, varicella virus vaccine live (oka/merck) (VARIVAX) (lot #W011623, expiration date: 06-APR-2024) underwent a temperature excursion at minus 10 degrees Celsius for 1400 hours. There was no previous temperature excursion.  On 26-JUL-2022, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (strength, dose, and route of administration were not provided; lot #W011623, expiration date: 06-APR-2024), administered for prophylaxis (Product storage error). There was no other AE (No adverse event).  This is one of 13 reports received from the same reporter.; Sender's Comments:  US-009507513-2209USA010264: US-009507513-2209USA010265: US-009507513-2209USA010266: US-009507513-2209USA010267: US-009507513-2209USA010268: US-009507513-2209USA010269: US-009507513-2209USA010270: US-009507513-2209USA010271: US-009507513-2209USA010272: US-009507513-2209USA010273: US-009507513-2209USA010274: US-009507513-2209USA010275:
Pt recv vax on 3/31/99; on 4/5/99 pt exp fever (103.8), dark pink pea-size spots on arms &legs; on 4/8/99 pt had pimple red spots on body
Allergies; Hives; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 12Mar2021 (Batch/Lot number: unknown) as dose 1, single and administration date 31Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALLERGY TO VACCINE (non-serious) with onset Mar2021, outcome "unknown", described as "Allergies"; URTICARIA (non-serious) with onset Mar2021, outcome "unknown", described as "Hives".  Additional information: Caller asking to speak with (withheld) and talking about setting up a checkup. Caller said he's done with the 1st dose of the vaccine on 12Mar2021 and the 2nd dose on 31Mar2021. Caller mentioned allergies and hives. Tried to confirm the reason for the call but the caller is unclear and hard to understand. Advised to call a facility or hospital if he's trying to set up an appointment for a checkup. Unable to gather demographics and unable to transfer. Unable to provide the PMI phone number. Created manual AE form.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a nurse practitioner refers to 18 patients who might have been vaccinated with doses of VAQTA (Lot # J003719, expiration date 27-SEP-2015) that were exposed to 31F for accumulative of 1 hour and 30 minutes between 04-OCT-2013 and 10-OCT-2013. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Vaccines given at 3:45 and at 3:52 red blotches, different sizes all over body, note small white pimple bumps in middle of red blotches. At 4:18 most blotches are faded or gone.
8:20 pm - Patient received Pfizer COVID-19 dose 2 vaccine at 3:41 pm. Came in to c/o severe headache, dizzy, vomiting, and chills. BP high initial 176/81 P: 76, 97.7, O2: 99%. Patient has hx of HTN ans took medicine in the am. IMT called 8:25 pm, assessed vitals  retaken (BP: 189/84; P:82 right arm; BP: 188/86, P: 82 left arm, and transported via wheelchair to  Emergency Center for evaluation.
Administered Vaccine after the 12 hour post-puncture expiration; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered Vaccine after the 12 hour post-puncture expiration) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 071F21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROCORTISONE, SPIRONOLACTONE, THYROID (ARMOUR THYROID) and FUROSEMIDE (LASIX [FUROSEMIDE]) for an unknown indication.    On 15-Nov-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered Vaccine after the 12 hour post-puncture expiration). On 15-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administered Vaccine after the 12 hour post-puncture expiration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medications include Arthritis pain relief medications. No treatment medications were provided by the reporter.  Initially the vial was punctured on 10-NOV-2021 at 20.00 and stored in refrigerator on same day. Post puncture the vial stored in fridge. The vial did not undergo any temperature excursions.   Most recent FOLLOW-UP information incorporated above includes: On 18-Nov-2021: Follow-up received reporter details, updated patient demographics, suspect product details, route of administration, expiration date and concomitant medications added
Received booster from expired vial; On 29Oct2021 they administered 15 Moderna COVID-19 booster half doses to patients; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received booster from expired vial) and UNDERDOSE (On 29Oct2021 they administered 15 Moderna COVID-19 booster half doses to patients) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Cancer.    On 29-Oct-2021 at 1:30 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 29-Oct-2021 at 1:30 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received booster from expired vial) and UNDERDOSE (On 29Oct2021 they administered 15 Moderna COVID-19 booster half doses to patients). On 29-Oct-2021 at 1:30 PM, EXPIRED PRODUCT ADMINISTERED (Received booster from expired vial) and UNDERDOSE (On 29Oct2021 they administered 15 Moderna COVID-19 booster half doses to patients) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided. The patient had no allergies to medication, food and other products. The patient had no acute illness at the time of vaccination or up to one month before. It was unknown if the patient took prescriptions, over the counter medications, dietary supplements or herbal remedies at the time of vaccination.  No treatment medication information was provided.
This spontaneous report as received from a nurse, refers to an unknown number of patients of unknown age and gender. Medical history and concurrent conditions were not provided.    On an unknown dates, the patients were vaccinated with improperly stored dose of RECOMBIVAX HB therapy type unknown (dose, frequency, route of administration and indication were not reported, lot # L016959 with expiration date: 12-MAR-2018). Concomitant medications were not reported. No adverse events were reported. The administered dose was stored in 47 F for 8 hours. There was no previous temperature excursions. Data logger was not involved. As of 30-NOV-2016, all telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1610USA003001: US-009507513-1610USA003003:US-009507513-1610USA003004: US-009507513-1610USA003005:US-009507513-1610USA003002: US-009507513-1610USA002738:,MERCK 1610USA003006:Mfr number.
pt began to have trembling of extremities; no loss of consciousness; awake & responsible; tx APAP & DPH;